Overview

Anastrozole Administration in Elderly Hypogonadal Men

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effects of sustained aromatase inhibitor therapy to reduce estrogen levels in elderly men with mild hypogonadism (a decreased level of sex hormones).
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute on Aging (NIA)
Treatments:
Anastrozole